课题基金 / 基金详情

Helicobacter pylori - cellular immunity and protection against multiple sclerosis

Helicobacter pylori - cellular immunity and protection against multiple sclerosis
幽门螺杆菌 - 细胞免疫和预防多发性硬化症
批准号:
1833939
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Multiple sclerosis (MS) is a demyelinating autoimmune disorder affecting the central nervous system (CNS), where inflammatory T-helper 1 (Th1) and Th17 cell responses damage the myelin sheath of neural axons and cause neurodegeneration. The balance between these cells and anti-inflammatory regulatory T-cell (Treg) responses is important in MS development and progression.H. pylori is a bacterial pathogen that colonises the human stomach from childhood. It is the major cause of peptic ulceration and gastric cancer, however it also induces a potent Treg response and beneficial roles have been described. We were the first to demonstrate protective effects of H. pylori against MS in a mouse model, and reported a lower prevalence of H. pylori amongst MS patients.This project will evaluate the influence of H. pylori on MS, and investigate the immunological mechanisms. H. pylori status of MS patients will be ascertained by serology, and epidemiological analyses will compare the course of MS in infected and uninfected patients (including disability scores, relapse rates, and responsiveness to therapies). Using flow cytometry and RT-qPCR, we will quantify peripheral blood Treg, Th1 and Th17 cells and investigate differences in their homing receptor expression for migration to the gastric mucosa rather than the CNS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
PPAR抑制剂治疗BRCA1基因缺陷合并H.pylori 感染胃癌的机制研究
  • 批准号:
    2026JJ80963
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    谢勇
  • 依托单位:
外泌体Galectin-3调控TGF-β1/Smad通路诱导氧化应激在H.pylori感染促动脉粥样硬化的机制研究
  • 批准号:
    2025JJ60667
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    夏秀娟
  • 依托单位:
H.pylori 感染通过FABP5 促进肝脏巨噬细胞M1 极化 在 NAFLD 发病中的作用及机制研究
  • 批准号:
    2024JJ5491
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    李荣
  • 依托单位:
miR-218在改善H.pylori诱导的FD患者胃粘膜炎症中的作用及机制研究
  • 批准号:
    CSTB2023NSCQ-MSX0428
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2023
  • 负责人:
    刘露路
  • 依托单位: